Rx Medicare

Chronic inflammatory demyelinating polyneuropathy (CIDP) is a debilitating, progressive neurological disorder that results in muscle weakness and fatigue and can severely impair motor skills. According to the GBS/CIDP Foundation International, CIDP affects two to seven individuals per 100,000 worldwide.

Read More…

Related Posts

• Rare pancreatic cancer patients may live longer when treated with radiation therapy
• MEDai Helps Medicare Part D Sponsors Adhere To CMS Medication Therapy Management Initiative
• Bipartisan Group Of Lawmakers Promotes Bill To Provide Medicare Coverage For Home Infusion Therapy Services
• Health Bill Deal ‘Close’ Though Some Democrats – And All Republicans – Hold Out
• Agency For Healthcare Research And Quality News And Numbers: High Cholesterol, Diabetes Lead Drug Spending For The Elderly
• John mccain’s Blatant Medicare Hypocrisy
• States’ Legislative Health Initiatives Stall
• Medicare Ends Contract With Fox Insurance Company Drug Plan
• Antiabortion Amendments Stalling Unrelated Bills In Ky. House
• Administration, Health Insurers Point Fingers At Each Other In Premium Hike Dust-Up
• President Announces Plans To Crack Down On Health Care Fraud
• Senate Poised To Pass COBRA Subsidy Extension, Medicare ‘Doc Fix’
• Does Medicare ‘Doughnut Hole’ Spur Increase In Foreign Drug Imports?
• Senate Test Vote Today On Bill To Extend COBRA Subsidy, Doc Fix And State Medicaid Funding
• GOP Rejects Obama’s Compromise On Health Care, Wants ‘New Approach’

Tags: cidp, derived, easing, plasma, therapy, treated

This entry was posted on Sunday, April 26th, 2009 at 6:04 pm and is filed under Uncategorized. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.